Comparison
2p21 Microdeletion Syndrome C4304537 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 2p21 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome C4304537
A rare genetic disorder involving deletion of genetic material on chromosome 2. It may affect multiple body systems and development. Management is tailored to individual symptoms.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
2p21 Microdeletion Syndrome C4304537
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
2p21 Microdeletion Syndrome C4304537
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome C4304537
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome C4304537
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
2p21 Microdeletion Syndrome C4304537
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
2p21 Microdeletion Syndrome C4304537
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-C4304537 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome C4304537 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Development may be affected, but specific delays are not established in the source. | Developmental delays may occur, with variable features. | Low |
| Multisystem involvement | Multiple body systems may be affected. | Features vary; multisystem involvement is not specifically established. | Moderate |
| Age at recognition | Onset is not established from the supplied data. | Recognition may occur from birth through early childhood. | Moderate |
When to favor each condition
Choose 2p21 Microdeletion Syndrome C4304537 when
Chromosomal testing shows a 2p21 deletion
The defining finding is loss of material at 2p21, not a duplication.
High
A rare congenital condition appears severe
The supplied severity label is severe, but severity alone cannot diagnose it.
Low
Multiple systems and development are affected
This pattern is compatible but nonspecific and requires genetic confirmation.
Low
Choose 14q11 2 Microduplication Syndrome C4749855 when
Testing shows extra material at 14q11.2
The defining finding is a small duplication of chromosome 14.
High
Developmental delay appears in early childhood
The supplied onset range is 0–5 years, but delay is not specific.
Moderate
Features are variable and moderate
This matches the supplied description, pending laboratory confirmation.
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome C4304537 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion involving 2p21. | May detect a microduplication at 14q11.2. | The genomic location and copy-number change distinguish them; clinician review is required. |
| Karyotype | A small deletion may not be visible. | A small duplication may not be visible. | A normal karyotype does not exclude either condition. |
| Targeted genetic confirmation | Confirms loss at the relevant 2p21 region. | Confirms gain at 14q11.2. | Result interpretation depends on size, genes involved, and clinical context. |
Prognosis comparison
2p21 Microdeletion Syndrome C4304537
- Outcome
- Long-term outcome is not established; the supplied severity label is severe.
- Factors
- Affected systems, developmental needs, deletion details, and available support may influence course.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is variable; the supplied severity label is moderate.
- Factors
- Degree of developmental delay, duplicated material, and response to supportive care may matter.
Time frame: Both are described as chronic; exact milestones or survival are not supplied.
Prognosis requires individualized clinician interpretation and should not be inferred from these labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible, but type and severity are not established. Developmental delays may occur and vary. Early developmental assessment is reasonable; no specific complication rate is supplied. |
| Multisystem medical needs | Multiple systems may require individualized care. Needs depend on the individual’s variable features. Neither description establishes particular organ complications. |
| Long-term support needs | Chronic course with potentially substantial support needs. Chronic course with supportive therapy and monitoring. Support should follow observed needs rather than the syndrome label alone. |
Patient education highlights
- HighGenetic confirmation
A suspected diagnosis should be confirmed and explained by a genetics clinician.
- HighIndividual variation
Features and needs can differ; the label does not predict every outcome.
- MediumNot contagious
Neither condition is communicable from person to person.